Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients

NCT05804409 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-04-07

No results posted yet for this study

Summary

to investigate the frequency of PEI in MAFLD

Conditions

  • Pancreatic Exocrine Insufficiency

Interventions

DIAGNOSTIC_TEST

FECAL ELASTASE

screening for pancreatic exocrine insufficiency in MAFLD patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-06-30
Completion
2024-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804409 on ClinicalTrials.gov